Overview

Determination of the ED50 and ED95 of Prophylactic Norepinephrine Infusion for Preventing Post-induction Hypotension in Elderly Patients Undergoing Major Abdominal Surgery

Status:
Recruiting
Trial end date:
2023-05-30
Target enrollment:
0
Participant gender:
All
Summary
The goal of this clinical trial is to determine the ED50 and ED95 of prophylactic norepinephrine infusion for preventing post-induction hypotension in elderly patients undergoing major abdominal surgery using up-and-down sequential method . The main question it aims to answer is: What is the effective concentration of prophylactic norepinephrine infusion for preventing post-induction hypotension in elderly patients. Participants will receive different concentrations of norepinephrine infusion at the beginning of anesthesia induction until 15 minutes after intubation.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Treatments:
Norepinephrine
Criteria
Inclusion Criteria:

- aged 65 to 80 years

- Undergoing major abdominal surgery

- American Society of Anesthesiologists (ASA) physical status of I/II/III

Exclusion Criteria:

- Patient refusal

- Severe untreated or uncontrolled hypertension despite medications

- Bradycardia (heart rate < 50 beat per minute)

- Cardiac morbidities, heart block greater than the first degree

- Severe hepatic and renal dysfunction

- hyperthyroidism

- vascular diseases

- BMI>30

- Monoamine oxidase inhibitors were used 2 weeks before surgery